×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Skip to main content
Tags: Coronavirus | Financial Markets | Health Topics | Infrastructure | Money | Vaccines | omicron

Countries Rush to Buy Experimental Antiviral COVID-19 Pills

Pfizer
Pfizer slogan "Science Will Win," as seen at its New York headquarters. (AP)

Thursday, 02 December 2021 11:25 AM

Merck & Co Inc has signed deals to sell over 6 million courses of its experimental COVID-19 pill molnupiravir to governments around the world as nations try to tame the pandemic. The treatment, which received its first regulatory approval globally in Britain, where it is planned to be marketed under the LAGEVRIO trademark, is not the only one in the game.

Last month U.S. peer Pfizer Inc halted early a trial of its antiviral drug Paxlovid after it proved to cut the risk of severe COVID-19 by 89%, outdoing the results seen with Merck's product.

While a review of both treatments is ongoing in the United States, a panel of expert advisers to the U.S. Food and Drug Administration (FDA) narrowly voted on Tuesday to recommend the agency authorize Merck's antiviral pill.

In the European Union, Merck's treatment is still under review by the European Medicines Agency (EMA). However, faced with rising COVID-19 cases, on Nov. 19 the regulator issued advice on using the pill for adults ahead of providing any wider recommendation. On the same day, EMA said it started review of Pfizer's Paxlovid.

Among EU countries, Germany said on Nov. 19 it is in talks with Pfizer, Merck (known in Europe under the MSD name) and "all those who have promising medicines" on COVID-19 treatment. Belgium said on Wednesday it is in talks with Merck on to buy 10,000 doses of the drugmaker's COVID-19 pill, adding the country is "in favor of a European joint procurement."

Following the emergence of the Omicron variant, a Merck executive said on Tuesday its experimental drug should have similar effects against any coronavirus variant. 

© 2022 Thomson/Reuters. All rights reserved.


StreetTalk
Merck & Co Inc has signed deals to sell over 6 million courses of its experimental COVID-19 pill molnupiravir to governments around the world as nations try to tame the pandemic.
omicron, COVID-19 vaccine and pill
272
2021-25-02
Thursday, 02 December 2021 11:25 AM
Newsmax Media, Inc.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the NewsmaxTV App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved